Announcements Trials
Browse Landscape

Status

Recruiting 47Active not recruiting 33Completed 13Not yet recruiting 9Terminated 4Withdrawn 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1

Interventions

Educational Status 5Interviews as Topic 4Methods 3Early Intervention, Educational 3Cisplatin 3Blood Specimen Collection 3pembrolizumab 2Surveys and Questionnaires 2Standard of Care 2Nivolumab 2Music Therapy 2Magnetic Resonance Imaging 2Gemcitabine 2Counseling 2zilucoplan 1tislelizumab 1somapacitan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1futibatinib 1fluorodopa F 18 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1dalpiciclib 1brexucabtagene autoleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Surveys and Questionnaires × 90 days × Clear all
NCT06967467 2026-06-05

RENEW-EVAL

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
80 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT07215039 2026-04-17

Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida

Mayo Clinic

Enrolling by invitation
1,200 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡